Effect of fluorouracil, leucovorin, and oxaliplatin with or without onartuzumab in epidermal growth factor receptor-2-negative, mesenchymal-epithelial transition-positive gastroesophageal adenocarcinoma: is it a real failure?

Document Type

Article

Publication Date

1-1-2018

Institution/Department

Surgery, Oncology

Journal Title

Transl Gastroenterol Hepatol

MeSH Headings

Leucovorin, onartuzumab, Oxaliplatin, Antibodies, Monoclonal, Fluorouracil, Adenocarcinoma, Epithelial-Mesenchymal Transition, ErbB Receptors

ISSN

2415-1289

First Page

58

Last Page

58

Share

COinS